News

  • Endometriosis study paves way for new diagnostics and treatments

    A major genetics study has found dozens of new signals linked to endometriosis, offering fresh insight into the biology driving the condition. Endometriosis is a systemic disease affecting around 10 per cent of females worldwide. It happens when tissue similar to the lining of the uterus grows outside it, causing pain, inflammation and fertility problems. [...]

  • First patients dosed in miscarriage trial

    The first patients have been dosed in a UK miscarriage trial testing a new intravaginal drug delivery platform for threatened miscarriage. The FREEDOM study is evaluating 400mg progesterone Callavid in patients diagnosed with luteal phase insufficiency, a condition in which progesterone levels may be too low to support early pregnancy, increasing the risk of infertility [...]

  • Women share stories rare pregnancy complication in awareness campaign

    A rare pregnancy complication has led to emergency surgery, including hysterectomies, after staff failed to detect it in affected women. Scores of women have come forward to tell their stories of how they were affected by placenta accreta spectrum, or PAS, since the launch in February of a campaign to raise awareness among NHS staff [...]

  • Women As One reveals 2026 Mentorship Award Winners

    Women As One has announced the winners of the 2026 Mentorship Awards, recognising six exceptional women physicians who are advancing cardiovascular research through mentorship, collaboration, and leadership. The Women As One Mentorship Awards are designed to accelerate the careers of women in cardiology by supporting impactful mentor-mentee partnerships. Through funding, structured guidance, and access to [...]

  • Mail order access to abortion drugs blocked by US appeals court

    A US appeals court has temporarily blocked mail-order access to mifepristone, a ruling that could severely limit access to the abortion drug nationwide. Abortion rights supporters said the decision was the most sweeping threat to abortion access since the supreme court rolled back abortion rights in 2022. Kelly Baden, vice-president at the Guttmacher Institute, an [...]

  • WHIS 2026 unveils agenda and first speakers for the leading women’s health summit

    By WHIS The Women’s Health Innovation Summit (WHIS) returns October 13–15, 2026 at Encore Boston Harbor, bringing together over 1,000 senior leaders from across the full spectrum of women’s health, including payers, providers, employers, pharma, digital health, investors, and policymakers. Super Early Bird tickets are now on sale. Now in its eighth year, WHIS is [...]

  • Sleep checks could unlock better menopause care, poll suggests

    Women aged 50 to 80 with menopause symptoms were more likely to report sleep problems than those without in a US national poll. In a cross-sectional analysis of 1,202 US women, investigators found that 56.4 per cent reported sleep problems overall. Among women with menopause-related symptoms, 75 per cent reported sleep problems, compared with 49.8 [...]

  • What Maternal Mental Health Month reveals about where postpartum support actually breaks down

    By Morgan Rose, chief science officer at Ema, and Lauren Scocozza, vice president of product at Willow May is Maternal Mental Health Month, and every year it surfaces a familiar set of statistics: 1 in 5 new mothers experiences postpartum depression or anxiety, most go unscreened, and the majority who are screened don't receive adequate [...]

  • Online abuse and deepfakes ‘pushing women out of public life’

    Deepfakes, AI-assisted rape and unwanted advances are pushing women out of public life, a report has found. Online violence against women in public life is becoming increasingly technologically sophisticated, with perpetrators able to use AI tools to fabricate intimate images of their targets. Survey responses suggest these attacks are often deliberate and coordinated, aiming to [...]

  • GLP-1 drugs do not increase pregnancy risks, study finds

    GLP-1 drugs taken before conception were not linked to higher pregnancy risks in new research, which suggested they may even offer some protection. Women of reproductive age are increasingly prescribed GLP-1 drugs for weight-management support, but the risks and benefits of using them before pregnancy remain poorly understood. The findings support continuing the use of [...]